Interventional Neuroradiology Market Capacity, Restraints, and Geography Survey 2019-2027

According to a new market research study titled ‘Interventional Neuroradiology Market – Global Analysis and Forecasts by Product, Disease and End User. The global interventional neuroradiology market is expected to reach US$ 3,254.55 Mn in 2027 from US$ 1,969.39 Mn in 2018. The market is estimated to grow with a CAGR of 5.9% from 2019-2027. The report highlights the trends prevalent in the global interventional neuroradiology market and the factors driving the market along with those that act as deterrents to its growth.

Get Sample Copy At:

The market for Interventional Neuroradiology is expected to grow significantly due to factor as increasing inclination of pharmaceutical and medical device manufacturers towards outsourcing, increasing patent cliffs and rising geriatric population coupled with the increasing production of drugs & medical devices. However, the challenge such as lack of skilled professionals for CMO likely to impact the growth of the market in the forecast period.

The players operating in interventional neuroradiology market are:- Balt Extrusion, Merit Medical Systems, Terumo Corporation, Medtronic, Penumbra, Inc., Stryker, DePuy Synthes, Boston Scientific Corporation, W. L. Gore & Associates, and MicroPort Scientific Corporation among others

Strategic Insights

Strategic acquisition and product launches were observed as the most adopted strategy in global interventional neuroradiology industry. Few of the recent product launch and acquisitions are listed below;

  • 2018: Balt USA, subsidiary of Balt Extrusion, received 510 (k) approval for the Optima Coil System in the US. The approval of the Optima Coil System makes it the first Balt USA product to be developed and approved for use in the US.
  • 2018: MicroVention, Inc., received the FDA Premarket Approval (PMA) for the WEB Aneurysm Embolization System for the treatment of intracranial wide neck bifurcation aneurysms. The WEB System is a unique, single-device treatment solution for wide neck bifurcation aneurysms, which may account for up to 35% of all aneurysms.
  • 2016: Merit Medical Systems, Inc. received 510(k) clearance for the SwiftNINJA Steerable Microcatheter.  The clearance aims to offer peripheral and coronary applications. With the exception of Japan, Merit has global distribution rights for the SwiftNINJA.


By Product

  • Neurovascular Embolization and Coiling Assist Devices
  • Embolic Coils
  • Flow Diversion Devices
  • Liquid Embolic Agents
  • Accessories
  • Microcatheters
  • Microguidewires

By Disease

  • Cerebral Aneurysms
  • Intra-Cranial Tumors
  • Acute Strokes
  • Other Diseases
  • By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Other End Users

By Geography

  • North America
  • Europe
  • Asia Pacific (APAC)
  • Middle East & Africa (MEA)
  • South America (SAM)

Buy Complete Report At :

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us
The Insight partners,
Phone: +1-646-491-9876
Email: [email protected]

Posted by on Monday August 19 2019, 1:30 AM EDT. All trademarks acknowledged. Filed under Healthcare. Comments and Trackbacks closed. Follow responses: RSS 2.0

Comments are closed

News Categories

Featured Press Releases

Log in